March 26 (Reuters) - Acorda Therapeutics Inc:
* ACORDA FILES MARKETING AUTHORIZATION APPLICATION FOR INBRIJA™ (LEVODOPA INHALATION POWDER)
* ACORDA THERAPEUTICS INC - ACORDA IS SEEKING MARKETING APPROVAL IN EUROPEAN UNION FOR INBRIJA
* ACORDA THERAPEUTICS INC - U.SFDA IS CURRENTLY REVIEWING A NEW DRUG APPLICATION FOR INBRIJA AND HAS SET AN ACTION DATE OF OCT 5, 2018 UNDER PDUFA Source text for Eikon: Further company coverage:
